✦ LIBER ✦

267: Impact of cyclosporine C2 monitoring on renal function in de novo heart transplant patients: 10-year experience

✍ Scribed by M. Cantarovich; N. Giannetti; M. deB. Edwardes; G. Fontaine; R. Chartier; E. Cyr; R. Cecere

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimization of cyclosporine exposure ut

✍ N. Maham; C. Cardella; D. Cattran; S. Fenton; C. O’Grady; J. Hamill; R. Smith; E 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 49 KB

C2 Therapeutic Drug Monitoring of Cyclos

✍ T. Puehler; L. Goepel; M.v. Tschirschnitz; U. Struckmeyer; M. Ernst; S. Ladenbur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 216 KB

396: Everolimus in de novo heart transpl

✍ A. Keogh; S.S. Wang; A. Zuckermann; H. Ross; M. Frigerio; H. Eisen; C. Bara; G. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Cyclosporine C2 Levels Have Impact on In

✍ Martin Iversen; Folke Nilsson; Jorma Sipponen; Hans Eiskjaer; Lena Mared; Stein 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Impact of the early reduction of cyclosp

✍ Pascale Boissonnat, Ségolène Gaillard, Catherine Mercier, Michel Redonnet, Berna 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 322 KB

Quantification of Interstitial Fibrosis

✍ A. Servais; V. Meas-Yedid; M. Buchler; E. Morelon; J.-C. Olivo-Marin; E. Thervet 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 237 KB